Triumph Capital Management Ishares Biotechnology ETF Transaction History
Triumph Capital Management
- $234 Million
- Q1 2024
A detailed history of Triumph Capital Management transactions in Ishares Biotechnology ETF stock. As of the latest transaction made, Triumph Capital Management holds 3,779 shares of IBB stock, worth $521,350. This represents 0.22% of its overall portfolio holdings.
Number of Shares
3,779
Previous 3,863
2.17%
Holding current value
$521,350
Previous $524,000
1.15%
% of portfolio
0.22%
Previous 0.23%
Shares
9 transactions
Others Institutions Holding IBB
# of Institutions
1,009Shares Held
33.5MCall Options Held
4MPut Options Held
6.48M-
Bank Of America Corp Charlotte, NC7.15MShares$987 Million0.09% of portfolio
-
Morgan Stanley New York, NY3.16MShares$436 Million0.03% of portfolio
-
Citigroup Inc1.98MShares$273 Million0.17% of portfolio
-
Royal Bank Of Canada Toronto, A61.47MShares$203 Million0.05% of portfolio
-
Jane Street Group, LLC New York, NY1.44MShares$198 Million0.05% of portfolio